Our top pick for
US stocks
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Australian Pharmaceutical Industries is a medical distribution business based in Australia. Australian Pharmaceutical Industries shares (API) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Australian Pharmaceutical Industries has a trailing 12-month revenue of around $4 billion. If you're looking to buy shares, check out the steps below.
How to buy shares in Australian Pharmaceutical Industries
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Australian Pharmaceutical Industries. Find the share by name or ticker symbol: API. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Australian Pharmaceutical Industries reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Australian Pharmaceutical Industries. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
Best overall broker
Our top pick for
Best low-cost broker
What's in this guide?
- Australian Pharmaceutical Industries key stats
- Compare share trading platforms
- Is Australian Pharmaceutical Industries stock a buy or sell?
- Australian Pharmaceutical Industries performance over time
- Are Australian Pharmaceutical Industries shares over-valued?
- Australian Pharmaceutical Industries's financials
- How volatile are Australian Pharmaceutical Industries shares?
- Does Australian Pharmaceutical Industries pay a dividend?
- Have Australian Pharmaceutical Industries shares ever split?
- Other common questions
Australian Pharmaceutical Industries stock price (ASX:API)
Use our graph to track the performance of API stocks over time.Australian Pharmaceutical Industries shares at a glance
Information last updated 2022-05-01.
| 52-week range | $1.0198 - $1.6964 |
|---|---|
| 50-day moving average | $1.5249 |
| 200-day moving average | $1.4944 |
| Target price | $1.53 |
| PE ratio | 510 |
| Dividend yield | $0.035 (2.29%) |
| Earnings per share (TTM) | $0.003 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
1 - 10 of 10
Is it a good time to buy Australian Pharmaceutical Industries stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Australian Pharmaceutical Industries price performance over time
Historical closes compared with the last close of A$1.53
| 3 months (2022-03-25) | 1.53 |
|---|---|
| 6 months (2021-12-24) | -11.56% |
| 1 year (2021-06-25) | 36.00% |
|---|---|
| 2 years (2020-06-26) | 34.80% |
| 3 years (2019-06-27) | 17.69% |
| 5 years (2017-06-27) | -17.96% |
Is Australian Pharmaceutical Industries under- or over-valued?
Valuing Australian Pharmaceutical Industries stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Australian Pharmaceutical Industries's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Australian Pharmaceutical Industries's P/E ratio
Australian Pharmaceutical Industries's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 510x. In other words, Australian Pharmaceutical Industries shares trade at around 510x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Australian Pharmaceutical Industries's PEG ratio
Australian Pharmaceutical Industries's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.53. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Australian Pharmaceutical Industries's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Australian Pharmaceutical Industries's EBITDA
Australian Pharmaceutical Industries's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $81 million (£0.0 million).
The EBITDA is a measure of a Australian Pharmaceutical Industries's overall financial performance and is widely used to measure a its profitability.
Australian Pharmaceutical Industries financials
| Revenue TTM | $4 billion |
|---|---|
| Operating margin TTM | 1.59% |
| Gross profit TTM | $503 million |
| Return on assets TTM | 2.59% |
| Return on equity TTM | 0.26% |
| Profit margin | 0.03% |
| Book value | 0.891 |
| Market capitalisation | $753.8 million |
TTM: trailing 12 months
Australian Pharmaceutical Industries share dividends
Dividend payout ratio: 1250% of net profits
Recently Australian Pharmaceutical Industries has paid out, on average, around 1250% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.29% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Australian Pharmaceutical Industries shareholders could enjoy a 2.29% return on their shares, in the form of dividend payments. In Australian Pharmaceutical Industries's case, that would currently equate to about A$0.035 per share.
Australian Pharmaceutical Industries's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 25 March 2022 (the "ex-dividend date").
Have Australian Pharmaceutical Industries's shares ever split?
Australian Pharmaceutical Industries's shares were split on 23 October 2009.
Australian Pharmaceutical Industries share price volatility
Over the last 12 months, Australian Pharmaceutical Industries's shares have ranged in value from as little as $1.0198 up to $1.6964. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Australian Pharmaceutical Industries's is 0.1833. This would suggest that Australian Pharmaceutical Industries's shares are less volatile than average (for this exchange).
Australian Pharmaceutical Industries overview
Australian Pharmaceutical Industries Limited engages in the wholesale distribution and retail of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia, New Zealand, and Asian markets. It offers health and beauty products through a network of Priceline and Priceline Pharmacy franchise stores, company-owned Priceline stores, and Clear Skincare network of clinics. The company also provides non-invasive aesthetic beauty services. Australian Pharmaceutical Industries Limited was incorporated in 1910 and is based in Camberwell, Australia. As of March 31, 2022, Australian Pharmaceutical Industries Limited operates as a subsidiary of WFM Investments Pty Ltd.
Australian Pharmaceutical Industries in the news
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
-
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
-
How to buy Leo lithium shares
Steps to owning and managing Leo lithium shares.
-
How to buy Besra Gold (BEZ) shares
Steps to owning and managing Besra Gold shares.
-
How to buy The Lottery Corporation (TLC) shares
Steps to owning and managing The Lottery Corporation shares.
-
How to buy BSP Financial Group (BFL) shares
Steps to owning and managing Endeavour Group shares.
Ask an Expert
